COMMUNIQUÉS West-GlobeNewswire

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
12/06/2026
-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria – -- Bezuclastinib [...]
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
12/06/2026
PALO ALTO, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non- [...]
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
12/06/2026
BOSTON, June 12, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that [...]
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
12/06/2026
Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial Results consistent with restoration of systemic PTH activity through serum calcium normalization, [...]
Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting
12/06/2026
Oral presentation at JDA features new data from the KT-621 Phase 1 study in healthy Japanese adults, with safety and PK/PD results consistent with previously reported KT-621 clinical studies KT-621 parallel Phase 2b [...]
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
12/06/2026
— Growing body of ORLADEYO ® clinical data and real-world evidence demonstrates consistent reductions in HAE attack burden and healthcare utilization across diverse patient populations — New post hoc analysis of Phase [...]
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12/06/2026
Rhapsido demonstrated statistically significant and clinically meaningful symptom control in twice as many patients vs placebo 1 , with favorable safety profile and no observed liver safety concerns 2 With global CIndU [...]
Le KFSH fait progresser les applications pratiques de l’IA pour transformer les soins de santé spécialisés
12/06/2026
RIYAD, Arabie saoudite, 12 juin 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) mettra en avant ses applications pratiques de l’intelligence artificielle lors de sa participation [...]
Evaxion receives Prix Galien UK Award for Best digital health solution
12/06/2026
COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien [...]
EAACI Calls for a "Vision Zero" Future Free from Allergy and Asthma Burden
12/06/2026
Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases ZURICH, June 12, 2026 (GLOBE NEWSWIRE) -- As allergic diseases continue to [...]
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
12/06/2026
— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile — —The ESLIM-02 study underscores sovleplenib’s potential to address critical unmet needs in a treatment landscape currently [...]
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
12/06/2026
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc . ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for [...]
Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds
12/06/2026
New York, NY, June 11, 2026 (GLOBE NEWSWIRE) -- Leaping Straight to Neurotoxin Treatments like Botox and Dysport, NextGen Medical Aesthetics Patients Frequently Skip Lower Commitment Services Qsight patient transaction [...]
Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis
11/06/2026
Santa Rosa, CA, USA, June 11, 2026 (GLOBE NEWSWIRE) -- FDA Breakthrough Device Designation Granted for XGal-3, an Investigational Apheresis Device Designed to Target Galectin-3 in Sepsis Patients Eliaz Therapeutics, Inc [...]
Hiding in Plain Sight: New Survey Exposes Awareness Gap Around the Second Most Common Type of Breast Cancer
11/06/2026
Boston, MA, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Despite nearly 50,000 new diagnoses each year and cases increasing faster than other breast cancer types, 4 in 5 Americans have never heard of lobular breast cancer. [...]
Precipio to Present at the Planet MicroCap Las Vegas
11/06/2026
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, [...]
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
11/06/2026
American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDNA alone GraftAssure™ assay doubles reliability of positive results in [...]
Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
11/06/2026
WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the [...]
Crescent Biopharma Announces Grants of Inducement Awards
11/06/2026
WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]

Pages